US Healthcare Technology Management Market worth 17.3 billion by 2028 - Ucommune International NASDAQU - Benzinga
| IMH Stock | THB 4.76 0.02 0.42% |
About 55% of Intermedical Care's investor base is interested to short. The analysis of current outlook of investing in Intermedical Care and suggests that many traders are impartial regarding Intermedical Care's prospects. Intermedical Care's investing sentiment shows overall attitude of investors towards Intermedical Care and.
Intermedical |
US Healthcare Technology Management Market worth 17.3 billion by 2028 - Ucommune International NASDAQU Benzinga
Read at news.google.com
 |
Intermedical Care Fundamental Analysis
We analyze Intermedical Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intermedical Care using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intermedical Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Profit Margin
Profit Margin Comparative Analysis
Intermedical Care is currently under evaluation in profit margin category among its peers. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Intermedical Care Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Intermedical Care stock to make a market-neutral strategy. Peer analysis of Intermedical Care could also be used in its relative valuation, which is a method of valuing Intermedical Care by comparing valuation metrics with similar companies.
Peers
Intermedical Care Related Equities
| IP | Inter Pharma | 1.24 |
| ||
| BCH | Bangkok Chain | 1.29 |
| ||
| HANA | Hana Microelectronics | 1.62 |
| ||
| EKH | Ekachai Medical | 2.36 |
| ||
| HUMAN | Humanica Public | 2.38 |
|
Other Information on Investing in Intermedical Stock
Intermedical Care financial ratios help investors to determine whether Intermedical Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Intermedical with respect to the benefits of owning Intermedical Care security.